Star Lake Bioscience (600866): Acquired Yipin to become a leader in amino acids. The bullish outlook for the company growth is supported by high growth in Sulai.

Successfully acquired Yipin Biotechnology, becoming a leading enterprise in corn deep processing. Star Lake Bioscience started with monosodium glutamate, and prior to the acquisition of Yipin Biotechnology, the company primarily engaged in food additives, pharmaceutical intermediates, and biological active pharmaceutical ingredient and formulation business, and since 2022 successfully acquired Yipin Bio.

Minsheng SecuritiesDec 5, 2024 00:00

Star Lake Bioscience (600866.SH): Yipin Group and its concerted actioner Tie Xiaorong have cumulatively reduced their shareholding by 1.68%.

On November 29, Glonghui reported that star lake bioscience (600866.SH) announced that the company received a "Notice of Results for Major Trade Shareholding Reduction" issued by Yipin Group and its concerted actor Tie Xiaorong. As of November 28, 2024, the shareholding reduction plan's period has expired, and Yipin Group along with Tie Xiaorong has cumulatively reduced their holdings in the company by 27,906,730 shares through block trading, accounting for 1.68% of the company's total equity. As of the disclosure date of this announcement, Yipin Group and Tie Xiaorong together hold 282,914,780 shares in the company, representing 17% of the company's total equity.

Gelonghui FinanceNov 29, 2024 19:31

Express News | Star Lake Bioscience: Deputy General Manager Zhang Fanping resigns.

BreakingsNov 15, 2024 17:12

Xingfa Alum’s subsidiary plans to sell part of the equity of Guangdong Guangxin Innovation Research Institute.

Xingfa Alum (00098) announced that on November 6, 2024, Guangdong Xingfa (an indirect wholly-owned subsidiary of the company), fspg hi-tech, and Star Lake Bioscience entered into an equity transfer agreement with Guangxin Holdings. According to the equity transfer agreement, Guangdong Xingfa, fspg hi-tech, and Star Lake Bioscience have agreed to sell and transfer 2.80% of the equity of Guangdong Guangxin Innovation Research Institute Co., Ltd., while Guangxin Holdings has agreed to acquire a total of 8.40% equity in the target company. The total consideration for the sale is approximately RMB 33.5594 million, with Guangdong Xingfa's consideration for the sale being approximately RMB 111 million.

Sina Hong Kong stocksNov 7, 2024 08:25

Xinghu Technology: Third Quarter Report 2024

SZSIOct 29, 2024 00:00 · Announcements

Third Quarter Report 2024

SZSIOct 29, 2024 00:00 · Announcements